查詢結果分析
來源資料
相關文獻
- 探討頭頸部癌合併頸部淋巴結腫大的病患使用二次IMRT治療計劃之必要性
- Oxyphilic Adenoma of parotid Gland: A Case Report and Literature Review
- Comparison of Immunogenicity of Simultaneous and Nonsimultaneous Vaccination with MMR and JE Vaccine Among 15-month-old Children
- Visualization of Facial Nerve in the Parotid Gland using Sonography: a Preliminary Observation
- 腮腺腫瘤之細針抽取細胞學檢查
- Seasonal Variation of Chickenpox, Mumps and Rubella in Taiwanese Children Estimated by Pediatric Clinics
- 腮腺內之神經鞘瘤--病例報告
- 成人腮腺海綿狀血管瘤--病例報告
- 顆粒性細胞肉瘤以頭頸部腫塊表現--病例報告
- 腮腺及下頜下腺之交感神經分佈
頁籤選單縮合
題 名 | 探討頭頸部癌合併頸部淋巴結腫大的病患使用二次IMRT治療計劃之必要性=Is Dual-Phase IMRT Required for the Patient of Head and Neck Cancer with Enlarged Cervical Lymph Nodes? |
---|---|
作 者 | 郭于誠; 吳東和; 黃光偉; 王雅玲; 鍾道生; 蘇文川; 陳東河; 邱仲峰; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 12:2 民94.06 |
頁 次 | 頁113-123 |
分類號 | 416.36 |
關鍵詞 | 二次電腦斷層定位IMRT治療計劃; 頭頸部癌; 部淋巴結腫大; 影像融合; 腮腺; 包履順形度; Dual-phase IMRT; Head and neck cancer; Cervical lymph nodes; Image fusion; The conformal index; Parotid gland; |
語 文 | 中文(Chinese) |
中文摘要 | 目的:探討頭頸部碰合併頸部淋巴結腫大的患者在強度控放射治療(intensity-modulated radiotherapy, IMRT)計劃使用二階段與單一階段電腦斷層影像(CT)的差別。 材料與方法:從2003年4月至2004年6月,共收集6位罹患頭頸部癌合併頸部淋巴結腫大的患者。我們對這6位病患安排第一次電腦斷層與核磁共振定位並進行影像融合。接著再由醫師定義出腫瘤(GTV, CTV)與重要器官。最後再由物理應用電腦治療計劃系統以反算法設計出第一次IMRT計劃來進行治療。我們採用的治療方式是同步化學放射治療(CCRT);化學治療部份是以Cisplatin 30 mg/wk靜脈輸注;放射治療部份採用SIB(simultaneous intensity boost) IMRT。當患者接受到4500 cGy時(計劃A)我們立即安排第二次電腦斷層與核磁共振定位,並根據第二次獲得的影像進行第二階段治療計劃的安排(計劃B)。此外我們將計劃A的調強圖譜(fluence map)套用到第二次的CT影像上形成模擬的計劃C,最後分析計劃B和C在劑量分布之差異。 結果:比較二次CT影像,我們發現病患的頸部淋巴結因接受4500 cGy而縮小甚至消失。若是未進行第二階段的IMRT計劃則會使患者的皮膚與腮腺落入高劑量區內。接著,在劑量分布上,我們發現:對CTV而言,其劑量包覆順形度上(conformity index)都是計劃B比計劃C好。對於腦幹而言,用t檢定來分析計劃B與計劃C發現法有明顯差別(p=0.9943),顯示計劃B與計劃C對於腦幹的保護相當。對於腮腺的淺葉與深葉而言,用t檢定來分析計劃B與C可以發現計劃B比較低(p<0.001),顯示使用二階段電腦斷層定位IMRT治療計劃可以明顯地再降低腮腺所接受的劑量。 結論:本研究顯示在執行IMRT治療時若患者體廓改變則必須調整治療計劃。若IMRT計劃未隨之調整,則其腮腺及皮慮劑量可能增加,腫瘤劑量曲線的順形度可能下降,影響治療的成效。 |
英文摘要 | Purpose: To discuss the differences of dose distribution between the dual-phase IMRT and one-phase IMRT in the patients of head-and-neck (H&N) cancers with enlarged cervical lymph nodes. Materials and Methods: From April 2003 to June 2004, we collected 6 patients of H&N cancers with enlarged cervical lymph nodes. Initially, we arranged first simulation by CT-MRI fusion for one-phase IMRT and prescribed 4500 cGy on GTV including enlarged lymph nodes (Plan A). Five weeks later, we arranged the second simulation by the same method to design dual-phase IMRT and prescribed 2700 cGy on GTV (Plan B). All 6 patients received concurrent chemoradiotherapy (CCRT) with cisplatin 30 mg/wk intravenously. The IMRT technique was simulataneous intensity boost (STB). Furthermore, we combined two CT images and superimposed the fluence map of Plan A onto the second CT images to get the Plan C, Finally, we compared Plan B with Plan C. Results: When we compared two CT images, we found that those enlarged lymph nodes already regressed or disappeared after plan A treatment, which made the skin and parotid gland fall into the high dose area. From the comparison of both plans, B had a much better conformal index than C for CTV. Using t test to analyze the D50%, D30% and Dmean of Plan b and C for the sparing of parotid glands, B had better results than C (p<0.001). Therefore, the dual-phase IMRT treatment planning can provide another way to significantly decrease the irradiation doses to parotid glands. Conclusion: This study indicate that if the patient’s contour changes without modifying the prior IMRT treatment planning, the doses of parotid glands and the skin will increase and the conformity of dose distribution will decrease, which affect the result of IMRT. |
本系統中英文摘要資訊取自各篇刊載內容。